HYALRIPAIR-10 Chondropreparant, 2 ml syringe

Bone and cartilage metabolic correctors

Regenerants and reparants

Nosological classification (ICD-10)

Arthritis unspecified

/p>

Coxarthrosis [hip arthrosis]

Honarthrosis [knee arthrosis]

Posttraumatic arthrosis of other joints

Other specified osteoarthritis

Orthritis unspecified

Other cartilage lesions

Other specified acquired musculoskeletal deformities

/p>

Unspecified trauma

Recuperation period after surgery

Recuperation period after fracture treatment

Active ingredient

Composition

Gel;

glass syringe with Luer-Lock tip 2 ml,

carton box 1

How to take, the dosage

In the joint cavity. The volume of GIARRIPAIR (chondropreparation) and the selection of the injection needle is determined by the physician individually depending on the anatomical and physiological characteristics and condition of the joint.

If there is an effusion in the joint, preliminary evacuation of excessive synovial fluid is recommended. Depending on the size of the joint it is necessary to inject up to 2 ml of GUALRIPAYER-10 gel material (chondropreparant) into the joint cavity once every 14 days for 6-8 weeks. The course is repeated after 6-12 months.

The treatment of several joints can be performed at one time. The HIALRIPAIER-10 (chondroparantine) gel therapy affects only the joints into which the material is injected. HIALRIPAIER-10 (chondroparantine) has no systemic effect.

Similarities